In vivo characterization of inhibitory anti-PD-1 antibody superagonists

被引：0
|
作者：
Akkaya, B. [1 ,2 ]
Davis, S. J. [1 ,2 ]
Cornall, R. J. [1 ,2 ]
机构：
[1] Univ Oxford, Nuffield Dept Clin Med, Oxford, England
[2] Univ Oxford, MRC Human Immunol Unit, Oxford, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] In vivo characterization of anti-PD-1 antibody REGN2810 in human PD-1 knock-in mice
    Burova, Elena
    Allbritton, Omaira
    Poueymirou, William
    Lai, Venus
    Waite, Janelle
    Skokos, Dimitris
    Papadopoulos, Nicholas
    Murphy, Drew
    Lowy, Israel
    Ioffe, Ella
    Thurston, Gavin
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [2] Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab
    Hutchins, Beth
    Starling, Gary C.
    McCoy, Mark A.
    Herzyk, Danuta
    Poulet, Frederique M.
    Dulos, John
    Liu, Liming
    Kang, Soonmo Peter
    Fayadat-Dilman, Laurence
    Hsieh, Mark
    Andrews, Christine L.
    Ayanoglu, Gulesi
    Cullen, Constance
    Malefyt, Rene de Waal
    Kastelein, Robert A.
    Le Saux, Sabine
    Lee, Julie
    Li, Sophie
    Malashock, Dan
    Sadekova, Svetlana
    Soder, George
    van Eenennaam, Hans
    Willingham, Aarron
    Yu, Ying
    Streuli, Michel
    Carven, Gregory J.
    van Elsas, Andrea
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (06) : 1298 - 1307
  • [3] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
  • [4] Discovery, development and characterization of a new class of therapeutic anti-PD-1 antibody
    Wang, Lei
    Amirina, Najmia
    Scheuplein, Fellix
    Spaulding, Vikki
    Wang, Yanyan
    Vadde, Sri
    Chiu, M. Isabel
    Doty, Daniel
    McQuade, Thomas
    Feng, Bin
    Ranganath, Sheila
    Nguyen, Anhco Cokey
    CANCER RESEARCH, 2016, 76
  • [5] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [6] Psoriasiform lesions induced by anti-PD-1 antibody
    Li-wen Zhang
    Yan Li
    Li-xin Fu
    Yong-hong Lu
    Tao Chen
    Rong-hua Xu
    European Journal of Dermatology, 2023, 33 : 179 - 181
  • [7] Agranulocytosis under Anti-PD-1 Antibody Therapy
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 78 - 79
  • [8] Psoriasiform lesions induced by anti-PD-1 antibody
    Zhang, Li-wen
    Li, Yan
    Fu, Li-xin
    Lu, Yong-hong
    Chen, Tao
    Xu, Rong-hua
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (02) : 179 - 181
  • [9] Granulomatous myositis associated with anti-PD-1 antibody
    Uchio, Naohiro
    Taira, Kenichiro
    Ikenaga, Chiseko
    Unuma, Atsushi
    Kadoya, Masato
    Kubota, Akatsuki
    Shimizu, Jun
    Toda, Tatsushi
    BRAIN PATHOLOGY, 2019, 29 : 32 - 33
  • [10] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
12345